FIGO good practice recommendations on cervical cerclage for prevention of preterm birth.


Journal

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174

Informations de publication

Date de publication:
Oct 2021
Historique:
entrez: 14 9 2021
pubmed: 15 9 2021
medline: 18 9 2021
Statut: ppublish

Résumé

Cervical cerclage is an intervention which when given to the right women can prevent preterm birth and second-trimester fetal losses. A history-indicated cerclage should be offered to women who have had three or more preterm deliveries and/or mid-trimester losses. An ultrasound-indicated cerclage should be offered to women with a cervical length <25 mm if they have had one or more spontaneous preterm birth and/or mid-trimester loss. In high-risk women who have not had a previous mid-trimester loss or preterm birth, an ultrasound-indicated cerclage does not have a clear benefit in women with a short cervix. However, for twins, the advantage seems more likely at shorter cervical lengths (<15 mm). In women who present with exposed membranes prolapsing through the cervical os, a rescue cerclage can be considered on an individual case basis, taking into account the high risk of infective morbidity to mother and baby. An abdominal cerclage can be offered in women who have had a failed cerclage (delivery before 28 weeks after a history or ultrasound-indicated [but not rescue] cerclage). If preterm birth has not occurred, removal is considered at 36-37 weeks in women anticipating a vaginal delivery.

Identifiants

pubmed: 34520055
doi: 10.1002/ijgo.13835
pmc: PMC9291060
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-22

Subventions

Organisme : March of Dimes

Investigateurs

Joe Leigh Simpson (JL)
Jane Norman (J)
Ana Bianchi (A)
Stephen Munjanja (S)
Catalina María Valencia González (CMV)
Ben W Mol (BW)

Informations de copyright

© 2021 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.

Références

Fetal Diagn Ther. 2021;48(5):327-332
pubmed: 33902036
PLoS One. 2017 Jun 1;12(6):e0178072
pubmed: 28570639
Am J Obstet Gynecol. 2015 Jun;212(6):788.e1-6
pubmed: 25637840
Am J Obstet Gynecol. 2009 Oct;201(4):375.e1-8
pubmed: 19788970
Obstet Gynecol. 2005 Jul;106(1):181-9
pubmed: 15994635
J Minim Invasive Gynecol. 2014 Nov-Dec;21(6):987-93
pubmed: 24907551
Br J Obstet Gynaecol. 1993 Jun;100(6):516-23
pubmed: 8334085
Cochrane Database Syst Rev. 2014 Sep 10;(9):CD009166
pubmed: 25208049
Fetal Diagn Ther. 2018;43(3):175-183
pubmed: 28796999
Lancet. 2006 Feb 11;367(9509):489-98
pubmed: 16473126
Lancet. 2004 Jun 5;363(9424):1849-53
pubmed: 15183621
J Reprod Med. 1994 Oct;39(10):788-90
pubmed: 7837125
Arch Gynecol Obstet. 2015 Dec;292(6):1255-60
pubmed: 26041325
Fetal Diagn Ther. 2018;43(4):241-249
pubmed: 29080890
Am J Obstet Gynecol. 2004 Oct;191(4):1311-7
pubmed: 15507959
Eur J Obstet Gynecol Reprod Biol. 2017 Jan;208:103-108
pubmed: 27918947
Am J Obstet Gynecol. 2020 Mar;222(3):261.e1-261.e9
pubmed: 31585096
Am J Obstet Gynecol MFM. 2020 Nov;2(4):100238
pubmed: 33345937
BMC Pregnancy Childbirth. 2017 Jul 6;17(1):215
pubmed: 28683739
J Obstet Gynaecol Res. 2016 Feb;42(2):148-57
pubmed: 26633738
Obstet Gynecol. 2015 Jul;126(1):125-35
pubmed: 26241265
Int J Gynaecol Obstet. 2021 Oct;155(1):19-22
pubmed: 34520055

Auteurs

Andrew Shennan (A)

Department of Women and Children's Health, King's College London, London, UK.

Lisa Story (L)

Department of Women and Children's Health, King's College London, London, UK.

Bo Jacobsson (B)

Department of Obstetrics and Gynecology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Genetics and Bioinformatics, Domain of Health Data and Digitalization, Institute of Public Health, Oslo, Norway.

William A Grobman (WA)

Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH